These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1351231)

  • 1. HIV-1 viraemia and influenza.
    Ho DD
    Lancet; 1992 Jun; 339(8808):1549. PubMed ID: 1351231
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals.
    Røsok B; Voltersvik P; Bjerknes R; Axelsson M; Haaheim LR; Asjö B
    Clin Exp Immunol; 1996 May; 104(2):203-7. PubMed ID: 8625509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of HIV-1 viraemia after seroconversion.
    Clementi M; Bagnarelli P; Menzo S; Valenza A; Manzin A; Varaldo PE
    Lancet; 1993 Jan; 341(8840):315-6. PubMed ID: 8093963
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza.
    Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):287-460. PubMed ID: 6103544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Technical note on the isolation of HIV from peripheral lymphomonocytes: use of PHA].
    Fiore JR; Angarano G; Fico C; Fracasso C; Carbonara S; Pastore G
    Boll Soc Ital Biol Sper; 1990 May; 66(5):499-503. PubMed ID: 2397110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma viraemia in seronegative HIV-1 infected individuals.
    Dis Markers; 1991; 9(6):351-2. PubMed ID: 1823326
    [No Abstract]   [Full Text] [Related]  

  • 7. H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir.
    Wagner TA; Huang HC; Salyer CE; Richardson KM; Weinberg A; Nachman S; Frenkel LM
    AIDS Res Ther; 2017 Feb; 14(1):7. PubMed ID: 28193244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection of normal human macrophage cultures: implication for silent infection.
    Dis Markers; 1991; 9(1):54-5. PubMed ID: 1742949
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: a Markov cohort model based on serial study participant hemoagglutination inhibition titers.
    Werker GR; Sharif B; Sun H; Cooper C; Bansback N; Anis AH
    Vaccine; 2014 Feb; 32(6):677-84. PubMed ID: 24355089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomical loci of HIV-associated immune activation and association with viraemia.
    Iyengar S; Chin B; Margolick JB; Sabundayo BP; Schwartz DH
    Lancet; 2003 Sep; 362(9388):945-50. PubMed ID: 14511927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV in pregnant women and their offspring: evidence for late transmission.
    Ehrnst A; Lindgren S; Dictor M; Johansson B; Sönnerborg A; Czajkowski J; Sundin G; Bohlin AB
    Lancet; 1991 Jul; 338(8761):203-7. PubMed ID: 1676777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative determination of cellular reactivity during infection with influenza virus A (H3N2)].
    Nekliudova LI; Gumennik AE; Khesin IaE; Amchenkova AM; Konstantinova OS
    Vopr Virusol; 1976; (3):276-82. PubMed ID: 824822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children.
    Zuccotti GV; Zenga A; Durando P; Massone L; Bruzzone B; Sala D; Riva E
    J Int Med Res; 2004; 32(5):492-9. PubMed ID: 15458281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV viraemia and seroconversion.
    Lu W; Eme D; Andrieu JM
    Lancet; 1993 Jan; 341(8837):113. PubMed ID: 8093378
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of methods for HIV isolation from monocytes and lymphocytes of seropositive asymptomatic hemophiliacs and homosexuals.
    Lemos RS; Rangan SR; Andes WA; Hyslop NE
    Braz J Med Biol Res; 1991; 24(11):1087-92. PubMed ID: 1822996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
    Tanzi E; Esposito S; Bojanin J; Amendola A; Trabattoni D; Pariani E; Pinzani R; Zanetti A; Principi N
    J Med Virol; 2006 Apr; 78(4):440-5. PubMed ID: 16482542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.
    Glesby MJ; Hoover DR; Farzadegan H; Margolick JB; Saah AJ
    J Infect Dis; 1996 Dec; 174(6):1332-6. PubMed ID: 8940228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Vaccination on Distribution of T Cell Subsets in Antiretroviral-Treated HIV-Infected Children.
    Thitilertdecha P; Khowawisetsut L; Ammaranond P; Poungpairoj P; Tantithavorn V; Onlamoon N
    Dis Markers; 2017; 2017():5729639. PubMed ID: 28694558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tool for predicting AIDS onset?
    Science; 1994 Feb; 263(5147):606. PubMed ID: 8303266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.